Literature DB >> 10430275

Silicone gel-filled breast and testicular implant capsules: a histologic and immunophenotypic study.

S L Abbondanzo1, V L Young, M Q Wei, F W Miller.   

Abstract

The immunophenotypic characteristics of silicone gel-filled breast and testicular implant capsules have not been well described. Therefore, we studied 17 paraffin-embedded tissue sections from 9 breast implant patients and 1 testicular implant patient to assess the type and extent of inflammatory responses present. Immunohistochemical analyses were performed on paraffin-embedded tissue sections for expression of CD20, CD45RO, betaF1, CD68, CD44, kappa and A immunoglobulin light chains, and bcl-XL (a member of the bcl-2 family of proteins involved in apoptosis). The most common histologic features included prominent T-cell and foamy macrophage reactions with foreign body giant cells and granulomas in a dense fibrovascular connective tissue. Foci of polyclonal plasma cells and acute inflammatory cells were variably present. In one case, there was reactive germinal center formation, a novel finding. A "pseudosynovium" at the implant capsule interface was present in the majority of cases as previously described; it showed reactivity with CD68. Thin strands of highly refractile, nonpolarizable material, consistent with silicone, were regularly noted in intra- and extracellular locations. The immunohistochemical results included reactivity of the majority of lymphocytes with CD45RO and/or betaF1 (confirming an anamnestic reactive T-cell phenotype), and reactivity of the macrophages, giant cells, and "pseudosynovium" with the macrophage/histiocyte marker, CD68. The reactive germinal centers were positive for CD20. Reactivity for CD44, an activation and intracellular adhesion marker, was frequently observed in the foamy macrophages and foreign body giant cells and has not been previously reported. The plasma cells demonstrated polyclonal immunoglobulin light-chain reactivity, consistent with a reactive process. These findings suggest that silicone implants induce chronic inflammatory responses in many adjacent capsules, which consist of anamnestically responding T cells, reactive B-lymphocytes, and macrophages.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10430275

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  7 in total

1.  The association of matrix Gla protein isomers with calcification in capsules surrounding silicone breast implants.

Authors:  Larry W Hunter; John C Lieske; Nho V Tran; Virginia M Miller
Journal:  Biomaterials       Date:  2011-08-11       Impact factor: 12.479

Review 2.  Foreign body reaction to biomaterials.

Authors:  James M Anderson; Analiz Rodriguez; David T Chang
Journal:  Semin Immunol       Date:  2007-12-26       Impact factor: 11.130

3.  Localized immunosuppressive environment in the foreign body response to implanted biomaterials.

Authors:  David M Higgins; Randall J Basaraba; April C Hohnbaum; Eric J Lee; David W Grainger; Mercedes Gonzalez-Juarrero
Journal:  Am J Pathol       Date:  2009-06-15       Impact factor: 4.307

4.  In vitro biocompatibility assessment of PHBV/Wollastonite composites.

Authors:  Haiyan Li; Wanying Zhai; Jiang Chang
Journal:  J Mater Sci Mater Med       Date:  2007-06-19       Impact factor: 3.896

5.  Histological assessment of tissue from large human bone defects repaired with β-tricalcium phosphate.

Authors:  Tomas Kucera; Pavel Sponer; Karel Urban; Ales Kohout
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-10-05

6.  Silicone Breast Implants: A Rare Cause of Pleural Effusion.

Authors:  Imam H Shaik; Bindu Gandrapu; Fernando Gonzalez-Ibarra; David Flores; Jyoti Matta; Amer K Syed
Journal:  Case Rep Pulmonol       Date:  2015-11-26

7.  Activation of macrophages by silicones: phenotype and production of oxidant metabolites.

Authors:  Pablo Iribarren; Silvia G Correa; Natalia Sodero; Clelia M Riera
Journal:  BMC Immunol       Date:  2002-07-01       Impact factor: 3.615

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.